期刊文献+

单剂量口服盐酸曲马多在蒙古族和汉族健康受试者的药代动力学 被引量:4

Pharmacokinetics of a single dose tramadol hydrochloride in Mongolian and Han healthy volunteers
下载PDF
导出
摘要 目的研究盐酸曲马多(镇痛药)在中国蒙古族和汉族健康受试者体内的药代动力学。方法选择蒙古族和汉族健康志愿者各10名(5男、5女),每人口服盐酸曲马多100mg后,用高效液相色谱-荧光检测法测定受试者血浆中盐酸曲马多的血药浓度,研究其药代动力学过程。结果蒙汉两族受试者口服盐酸曲马多后,药时曲线均符合一室开放模型,主要药代动力学参数:t1/2分别为(6.24±1.02)、(6.30±1.2)h,tmax分别为(2.40±0.74)、(1.95±0.37)h,Cmax分别为(0.40±0.08)、(0.42±0.09)mg.L-1,AUC0-36分别为(4.30±1.26)、(4.47±1.32)mg.h.L-1,AUC0-∞分别为(4.46±1.32)、(4.65±1.39)mg.h.L-1。结论服用盐酸曲马多后,汉族、蒙古族Cmax、AUC0-t、AUC0-∞个体间差异较大;但同一民族受试者单剂量口服曲马多后的药代动力学参数无显著性差异(P>0.05)。 Objective To investigate the pharmacokinetics of tramadol hydrochloride in Mongolian and Han healthy volunteers. Methods Ten healthy volunlteers (5 male ,5 female) in every nation were given a single oral dose ( 100 mg) of tramadol capsule respectively. Blood samples were determined by HPLC - fluorescence method and the pharmacoki- netic parameters were calculated by Das Ver 2.0 software. Results The plasma concentration - time curves of tramadol are both fitted to one - compartment model after an oral tramadol capsule in single dose (100 mg) . The main pharmacokinetic parameters of Mongolian and Han were as follows: t1/2 were (6.24 ± 1.02 ), (6.30 ± 1.2 ) h; tmax were (2.40 ± 0.74) ,(1.95 ±0.37) h;Cmax were (0.40 ±0.08),(0.42±0.09) mg·h·L^-1;AUC0-36were (4.30±1.26),(4.47 ±1.32) mg·h·L^-1; AUC0-∞ were(4.46 ±1. 32), (4.65 ± 1.39) mg·h·L^-1,respectively. Conclusion Individual difference is significant in Cmax, AUC0-t, AUC0-∞ after an oral tramadol capsule, but the pharmacokinetic parameers obtained from our study showed no significant difference between Mongolian and Han (P 〉 0.05).
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2008年第2期126-129,共4页 The Chinese Journal of Clinical Pharmacology
基金 全军医学科学技术研究“十一五”计划科技攻关课题基金资助项目(06G023)
关键词 盐酸曲马多 药代动力学 蒙古族:汉族 高效液相色谱-荧光检测 tramadol hydrochloride pharmacokinetics Mongolian tan HPLC - fluorescence
  • 相关文献

参考文献6

二级参考文献38

  • 1李桦,王宁,乔建忠,王淑范,万红.盐酸曲马多片剂的药代动力学和相对生物利用度[J].中国临床药理学杂志,1995,11(1):28-32. 被引量:20
  • 2孙国庆,朱颖,谷丽,平其能.反相高效液相色谱-荧光法检测血清中盐酸曲马多[J].中国药科大学学报,1996,27(8):476-479. 被引量:6
  • 3江明性,药理学(第4版),1996年,126页
  • 4FENG H J, HUANG S L,WANG W,et al. The induction effect of rifampicin on activity of mephenytoin 4' - hydroxylase related to M1mutation of CYP2C19 and gene dose[J ]. Br J Clin Pharmacol, 1998,45:27-29.
  • 5XIE H G, STEIN C M,KIM R B, et al. Wood AJ (1999). Frequency of functionally important beta- 2 adrenoceptor polymorphisms varies markedly among African- American, Caucasian and Chinese individuals[J]. Pharmacogenetics, 1999(9) :511 - 516.
  • 6ZHOU H H,KOSHAKJI R P,Silberstein D J ,et al. Racial differences in drug response: Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American Whites[J]. N Eng J Med, 1989,320:565 - 570.
  • 7ZHOU H H,SILBERSTEIN D J, KOSHAKJI R P,WOODA J J. Interindividual differences in beta- receptor density contribute to variability in response to beta- adrenoceptor antagonists[J]. Clin Pharmacol Ther. 1989,45:587-592.
  • 8ZHOU H H,ADEDOYIN A, WILKINSON G R. Differences in plasma binding of drug between Caucasians and Chinese[J]. Clin Pharmacol Ther, 1990.48:10-17.
  • 9WOOD AJJ, ZHOU H H. Ethnic differences in drug responses[J].Clin Pharmacokin, 1991,20: 350 - 373.
  • 10XIE H G, XU Z H, LUO X, et al. Genetic polymorphisms of debrisoquine and S - mephenytoin oxidation metabolm in Chinese populations: a meta- analysis[J]. Pharmacogenetics, 1996(6) :235 - 238.

共引文献45

同被引文献25

  • 1谭志荣,欧阳冬生,周淦,王连生,李智,王丹,陈国林,黄松林,刘英姿,胡东莉,周宏灏.高效液相色谱离子阱质谱联用法同时测定人血浆中曲马多和对乙酰氨基酚浓度[J].药物分析杂志,2005,25(7):795-798. 被引量:8
  • 2S H Gan, R Ismail, W A Wan Adnan,et al. Method development and validation of a high - performance liquid chromatographic method for tramadol in human plasma using liquid - liquid extraction. Journal of Chromatography B ,2002,772 : 123.
  • 3Milan Nobilis,Jiri Psstera,Pavel Anzenbacher,et al. High -performance liquid chromatographic determination of tramadol in human plasma. Journal of Chromatography B, 1996,681 : 177.
  • 4Mohammad - Reza Rouini, Yalda Hosseinzadeh Ardakani, Faezeh Sohani, et al. Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. Journal of Chromatography B ,2006,830:207.
  • 5Ardakani YH, Mehvar R, Foroumadi A, et al.Enantioselec- rive determination of tramadol and its main phase I me- tabolites in human plasma by high-performance liquid chromatography[J]. Journal of Chromatography B, 2008,864(1/2):109.
  • 6Silva MF, Schramm SG, Kano EK, et al. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy brazilian volunteers[J]. Clinical Therapeutics, 2010,32(4) : 758.
  • 7Curticapean A, Muntean D, Curticapean M, et al. Optimi- zed HPLC method for tramadol and O-desmethyl tramad- ol determination in human plasma[J]. Journal Biochemi- cal Biophysical Methods, 2008,70 (6) : 1 304.
  • 8Kirchheiner J, Keulen JTHA, Bauer S, et al. Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol[J]. Journal of Clinical Psychopharmacology, 2008,28( 1 ) : 78.
  • 9Rouini MR, Ghazi-Khansari M, Ardakani YH, et al. A dis- position kinetic study of tramadol in rat perfused liver[J]. Biopharmaceutics & Drug Disposition, 2008,29 (4) : 231.
  • 10Saccomanni G, Carlo SD, Giorgi M, et al. Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/ MS in urine of dogs[J]. Journal of Pharmaceutical and BiomedicalAnalysis,2010,53(2) : 194.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部